These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 8270496)

  • 1. Synthesis and biological activity of derivatives of glycopeptide antibiotics eremomycin and vancomycin nitrosated, acylated or carbamoylated at the N-terminal.
    Pavlov AY; Berdnikova TF; Olsufyeva EN; Lazhko EI; Malkova IV; Preobrazhenskaya MN; Testa RT; Petersen PJ
    J Antibiot (Tokyo); 1993 Nov; 46(11):1731-9. PubMed ID: 8270496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the glycopeptide framework in the antibacterial activity of hydrophobic derivatives of glycopeptide antibiotics.
    Printsevskaya SS; Pavlov AY; Olsufyeva EN; Mirchink EP; Preobrazhenskaya MN
    J Med Chem; 2003 Mar; 46(7):1204-9. PubMed ID: 12646030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity relationship studies of a series of antiviral and antibacterial aglycon derivatives of the glycopeptide antibiotics vancomycin, eremomycin, and dechloroeremomycin.
    Printsevskaya SS; Solovieva SE; Olsufyeva EN; Mirchink EP; Isakova EB; De Clercq E; Balzarini J; Preobrazhenskaya MN
    J Med Chem; 2005 Jun; 48(11):3885-90. PubMed ID: 15916441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N'-(alpha-aminoacyl)- and N'-alpha-(N-alkylamino)acyl derivatives of vancomycin and eremomycin. II. Antibacterial activity of N'-(alpha-aminoacyl)- and N'-alpha-(N-alkylamino)acyl derivatives of vancomycin and eremomycin.
    Plattner JJ; Chu D; Mirchink EP; Isakova EB; Preobrazhenskaya MN; Olsufyeva EN; Miroshnikova OV; Printsevskaya SS
    J Antibiot (Tokyo); 2007 Apr; 60(4):245-50. PubMed ID: 17456974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modification of glycopeptide antibiotic eremomycin by the action of alkyl halides and study on antibacterial activity of the compounds obtained.
    Pavlov AY; Olsufyeva EN; Berdnikova TF; Malkova IV; Preobrazhenskaya MN; Risbridger GD
    J Antibiot (Tokyo); 1994 Feb; 47(2):225-32. PubMed ID: 8150719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eremomycin pyrrolidide: a novel semisynthetic glycopeptide with improved chemotherapeutic properties.
    Olsufyeva EN; Shchekotikhin AE; Bychkova EN; Pereverzeva ER; Treshalin ID; Mirchink EP; Isakova EB; Chernobrovkin MG; Kozlov RS; Dekhnich AV; Preobrazhenskaya MN
    Drug Des Devel Ther; 2018; 12():2875-2885. PubMed ID: 30237697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and mode of action of hydrophobic derivatives of the glycopeptide antibiotic eremomycin and des-(N-methyl-D-leucyl)eremomycin against glycopeptide-sensitive and -resistant bacteria.
    Printsevskaya SS; Pavlov AY; Olsufyeva EN; Mirchink EP; Isakova EB; Reznikova MI; Goldman RC; Branstrom AA; Baizman ER; Longley CB; Sztaricskai F; Batta G; Preobrazhenskaya MN
    J Med Chem; 2002 Mar; 45(6):1340-7. PubMed ID: 11882003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Design of Novel Carboxamides of Eremomycin and Vancomycin with 4- or 3-Amino Methyl Phenyl Boric Acid and Their Investigation].
    Bychkova EN; Korolev AM; Olsufyeva EN; Mirchink EP; Isakova EB
    Antibiot Khimioter; 2015; 60(9-10):7-11. PubMed ID: 27141632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reductive alkylation of glycopeptide antibiotics: synthesis and antibacterial activity.
    Cooper RD; Snyder NJ; Zweifel MJ; Staszak MA; Wilkie SC; Nicas TI; Mullen DL; Butler TF; Rodriguez MJ; Huff BE; Thompson RC
    J Antibiot (Tokyo); 1996 Jun; 49(6):575-81. PubMed ID: 8698642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Non-natural aglycones of glycopeptide antibiotics of the vancomycin group. Synthesis and antibacterial activity].
    Pavlov AIu; Olsuf'eva EN; Miroshnikova OV; Reznikova MI; Lazhko EI; Malabarba A; Ciabatti R; Preobrazhenskaia MN
    Bioorg Khim; 1997 May; 23(5):410-21. PubMed ID: 9290051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chemical modification of glycopeptide antibiotics].
    Pavlov AIu; Preobrazhenskaia MN
    Bioorg Khim; 1998 Sep; 24(9):644-62. PubMed ID: 9813730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-activity relationships in the series of eremomycin carboxamides.
    Miroshnikova OV; Printsevskaya SS; Olsufyeva EN; Pavlov AY; Nilius A; Hensey-Rudloff D; Preobrazhenskaya MN
    J Antibiot (Tokyo); 2000 Mar; 53(3):286-93. PubMed ID: 10819300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new type of chemical modification of glycopeptides antibiotics: aminomethylated derivatives of eremomycin and their antibacterial activity.
    Pavlov AY; Lazhko EI; Preobrazhenskaya MN
    J Antibiot (Tokyo); 1997 Jun; 50(6):509-13. PubMed ID: 9268008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Experimental study of the antibacterial activity and chemotherapeutic efficacy of the novel glycopeptide eremomycin].
    Malikova IV
    Antibiot Khimioter; 1989 Jan; 34(1):52-6. PubMed ID: 2543344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carboxamides and hydrazide of glycopeptide antibiotic eremomycin. Synthesis and antibacterial activity.
    Pavlov AY; Berdnikova TF; Olsufyeva EN; Miroshnikova OV; Filipposyanz ST; Preobrazhenskaya MN; Sottani C; Columbo L; Goldstein BP
    J Antibiot (Tokyo); 1996 Feb; 49(2):194-8. PubMed ID: 8621361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A modification of the N-terminal amino acid in the eremomycin aglycone.
    Miroshnikova OV; Berdnikova TF; Olsufyeva EN; Pavlov AY; Reznikova MI; Preobrazhenskaya MN; Ciabatti R; Malabarba A; Colombo L
    J Antibiot (Tokyo); 1996 Nov; 49(11):1157-61. PubMed ID: 8982345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N'-(alpha-aminoacyl)- and N'-alpha-(N(alpha)-alkylamino)acyl derivatives of vancomycin and eremomycin. I. Synthesis of N'-(alpha-aminoacyl)- and N'-alpha-(N(alpha)-alkylamino)acyl derivatives of vancomycin and eremomycin by selective aminoacylation of the amino sugar of the disaccharide branch.
    Preobrazhenskaya MN; Olsufyeva EN; Miroshnikova OV; Plattner JJ; Chu D; Printsevskaya SS
    J Antibiot (Tokyo); 2007 Apr; 60(4):235-44. PubMed ID: 17456973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new series of glycopeptide antibiotics incorporating a squaric acid moiety. Synthesis, structural and antibacterial studies.
    Sztaricskai F; Batta G; Herczegh P; Balázs A; Jeko J; Roth E; Szabó PT; Kardos S; Rozgonyi F; Boda Z
    J Antibiot (Tokyo); 2006 Sep; 59(9):564-82. PubMed ID: 17136889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Eremomycin--a new antibiotic of the polycyclic glycopeptide group].
    Gauze GF; Brazhnikova MG; Lomakina NN; Gol'dberg LE; Laĭko AV
    Antibiot Khimioter; 1989 May; 34(5):348-52. PubMed ID: 2742419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Eremomycin--a new antibiotic from the cyclic glycopeptide group].
    Gauze GF; Brazhnikova MG; Laĭko AV; Sveshnikova MA; Preobrazhenskaia TP
    Antibiot Med Biotekhnol; 1987 Aug; 32(8):571-6. PubMed ID: 3674837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.